WHO panel issues strong advice against hydroxychloroquine for Covid-19
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
THURSDAY, MAY 26, 2022
THURSDAY, MAY 26, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
WHO panel issues strong advice against hydroxychloroquine for Covid-19

Coronavirus chronicle

Reuters
02 March, 2021, 10:20 am
Last modified: 02 March, 2021, 10:50 am

Related News

  • WHO condemns Russia's aggression in Ukraine in rare vote
  • Tedros re-elected as WHO director general - German minister
  • No monkeypox patient in Bangladesh: BSMMU VC
  • WHO says monkeypox outbreak 'containable', confirms 131 cases outside Africa
  • WHO says no urgent need for mass monkeypox vaccinations

WHO panel issues strong advice against hydroxychloroquine for Covid-19

"The anti-inflammatory drug should not be used in the fight against the pandemic and is “not worthwhile” exploring in further research studies of possible Covid-19 treatments"

Reuters
02 March, 2021, 10:20 am
Last modified: 02 March, 2021, 10:50 am
A pharmacist displays a box of Hydroxychloroquine at the CHR Centre Hospitalier Regional de la Citadelle Hospital amid the coronavirus disease in Liege, Belgium, June16, 2020/ Reuters
A pharmacist displays a box of Hydroxychloroquine at the CHR Centre Hospitalier Regional de la Citadelle Hospital amid the coronavirus disease in Liege, Belgium, June16, 2020/ Reuters

The drug hydroxychloroquine, once touted by Donald Trump as a pandemic "game-changer", should not be used to prevent Covid-19 and has no meaningful effect on patients already infected, a World Health Organization expert panel said on Tuesday.

The anti-inflammatory drug should not be used in the fight against the pandemic, the WHO's Guideline Development Group (GDG) expert panel wrote in the BMJ British medical journal, and is "not worthwhile" exploring in further research studies of possible Covid-19 treatments.

This "strong recommendation", the experts said, is based on high-certainty evidence from six randomised controlled trials involving more than 6,000 participants both with and without known exposure to Covid-19.

Former US President Trump said last March that hydroxychloroquine could be a game-changer in the coronavirus pandemic. He also said he was taking it himself, even after the US medicines regulator, the Food and Drug Administration (FDA), advised that its efficacy and safety were unproven.

But the WHO's experts said they now "judged that almost all people would not consider this drug worthwhile".

"The panel considers that this drug is no longer a research priority and that resources should rather be oriented to evaluate other more promising drugs to prevent Covid-19," they wrote.

The WHO noted in a statement that the recommendation is a so-called "living guideline" on potential drugs for Covid-19.

The guidelines, which can be updated as new evidence emerges, are designed to advise doctors and healthcare providers on managing the respiratory disease and help them make better decisions for patients.

Top News

hydroxychloroquine / COVID-19 / WHO / WHO guidelines / World Health Organization (WHO) / WHO’s Guideline Development Group (GDG)

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Ctg port Asia’s least efficient for container handling: World Bank
    Ctg port Asia’s least efficient for container handling: World Bank
  • Photo: Bloomberg
    Bigger food crisis can be averted if Asia remembers not to panic
  • One exchange rate for all to ease dollar volatility
    One exchange rate for all to ease dollar volatility

MOST VIEWED

  • People in protective suits cross a street during lockdown, amid the coronavirus disease (COVID-19) pandemic, in Shanghai, China, May 26, 2022. REUTERS/Aly Song
    Shanghai heading out of lockdown but China still lost in economic gloom
  • A woman wearing a face mask crosses a road at the Central Business District (CBD), amid the coronavirus disease (Covid-19) outbreak in Beijing, China May 10, 2022. REUTERS/Carlos Garcia Rawlins
    Tightening Covid net, Beijing deals out punishments, stark warnings
  • A medical worker takes a swab sample from a person for a nucleic acid test at a makeshift testing site, amid the coronavirus disease (Covid-19) outbreak, in Beijing, China May 23, 2022. REUTERS/Tingshu Wang
    Beijing ramps up Covid quarantine, Shanghai residents decry uneven rules
  • A vial labelled with the Pfizer-BioNTech coronavirus disease (Covid-19) vaccine is seen in this illustration picture taken March 19, 2021. Photo :Reuters
    Pfizer says 3 Covid shots protect children under 5
  • A medical worker takes a swab sample from a person for a nucleic acid test at a makeshift testing site, amid the coronavirus disease (Covid-19) outbreak, in Beijing, China May 23, 2022. REUTERS/Tingshu Wang
    Beijing urges millions to keep working from home amid Covid outbreak menace
  • Picture: PTI
    Saudi Arabia bans travel to India, 15 other countries over Covid outbreaks

Related News

  • WHO condemns Russia's aggression in Ukraine in rare vote
  • Tedros re-elected as WHO director general - German minister
  • No monkeypox patient in Bangladesh: BSMMU VC
  • WHO says monkeypox outbreak 'containable', confirms 131 cases outside Africa
  • WHO says no urgent need for mass monkeypox vaccinations

Features

Photo caption: Business models are already being hit by climate risk. It is the function of regulators to force banks to pay attention to the future risks to businesses. Photo: Bloomberg

HSBC and its discordant climate songbook

7h | Panorama
Illustration: TBS

Should Belayets be allowed to return to school at 55?

11h | Pursuit
Impact Hub Dhaka is designed to cater to connectivity, offering lots of communal areas where you can chat over coffee, watch a webinar as a group or even host events. Photo: Courtesy

Inside Impact Hub: The surprising benefits of working in a co-working space

12h | Pursuit
Pacific Jeans uses sustainable technology in washing and finishing, and now has the facility to wash with zero water. Photo: Courtesy

How big dreams and smart investment made Pacific Jeans a denim exporting giant 

13h | Panorama

More Videos from TBS

Inflation changes lives of limited-income people

Inflation changes lives of limited-income people

6m | Videos
 Vat on locally-made mobile phones, fridges may increase prices

Vat on locally-made mobile phones, fridges may increase prices

51m | Videos
Local brands dominate country’s refrigerator market

Local brands dominate country’s refrigerator market

56m | Videos
5 latest exciting movies

5 latest exciting movies

5h | Videos

Most Read

1
Tk100 for bike, Tk2,400 for bus to cross Padma Bridge
Bangladesh

Tk100 for bike, Tk2,400 for bus to cross Padma Bridge

2
Bangladesh at risk of losing ownership of Banglar Samriddhi
Bangladesh

Bangladesh at risk of losing ownership of Banglar Samriddhi

3
BSEC launches probe against Abul Khayer Hero and allies
Stocks

BSEC launches probe against Abul Khayer Hero and allies

4
Photo: Courtesy
Panorama

Misfit Technologies: A Singaporean startup rooted firmly in Bangladesh

5
Illustration: TBS
Banking

Let taka slide

6
Photo: Collected
Industry

Spanish recycled cotton producer opens new facility in Bangladesh

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab